LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 106 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $0 | – | 34 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 34 | 0.0% | 0.00% | – |
Q1 2019 | $0 | – | 34 | 0.0% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 34 | -99.2% | 0.00% | – |
Q3 2018 | $48,000 | -2.0% | 4,462 | +8.2% | 0.00% | – |
Q2 2018 | $49,000 | – | 4,122 | +7394.5% | 0.00% | – |
Q1 2018 | $0 | – | 55 | -19.1% | 0.00% | – |
Q4 2017 | $0 | – | 68 | +74.4% | 0.00% | – |
Q3 2017 | $0 | -100.0% | 39 | -77.7% | 0.00% | – |
Q2 2017 | $3,000 | 0.0% | 175 | -28.0% | 0.00% | – |
Q2 2016 | $3,000 | 0.0% | 243 | -3.6% | 0.00% | – |
Q1 2016 | $3,000 | 0.0% | 252 | +3.7% | 0.00% | – |
Q4 2015 | $3,000 | 0.0% | 243 | 0.0% | 0.00% | – |
Q3 2015 | $3,000 | +50.0% | 243 | +3.4% | 0.00% | – |
Q2 2015 | $2,000 | – | 235 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |